secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0001193125-25-159026
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics appoints Steven Pfanstiel as CFO; reaffirms Q2 & FY2025 guidance
----------------------------------------------------------------------------

- Pfanstiel named CFO effective July 15, replacing retiring Steve Furlong (through March 2026).
- Pfanstiel previously CFO/COO of Marinus Pharmaceuticals; 20+ years medical device/pharma experience.
- Inducement grant of 400,000 RSUs vesting over 3-4 years; base salary $480k, 50% target bonus.
- Reaffirms Q2 and full-year 2025 guidance; targets positive cash flow in Q3 2025.
- Outgoing CFO Furlong remains as Senior Advisor to CEO through end of March 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000119312525159026/0001193125-25-159026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000119312525159026/d34717d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-159026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer